The Motley Fool
13 Sept 2026, 08:15 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
4 claims · each scored for market impact
Hims & Hers Health reported a 12 percentage point year-over-year decline in gross margin to 64%. — Significant margin compression suggests that new growth areas, such as weight-loss treatments, are eroding overall profitability.
-0.60The company's adjusted EBITDA declined 26.7% year-over-year to $60.3 million in Q2. — A sharp drop in adjusted EBITDA indicates that operating costs are rising faster than revenue, raising risks for valuation.
-0.50Hims & Hers Q2 revenue rose 38% year-over-year to $753 million, driven by a 19% increase in subscribers and a 21% rise in revenue per subscriber. — Strong top-line growth and increasing monetization per user provide a fundamental bullish case for expansion.
+0.40Continue reading
5 related stories
Search tags
U.S. revenue growth lagged behind the overall rate, increasing only 16% year-over-year in Q2. — Slower growth in the core domestic market suggests that overall growth is heavily dependent on international acquisitions.
-0.20Which stocks this story touches
The analyst projects a potential 55.7% upside based on revenue growth and subscriber increases, despite some margin concerns.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
17h ago
